Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the cardiac troponin market grown in recent years?

The cardiac troponin market has been growing swiftly, set to increase from $3.85 billion in 2024 to $4.25 billion in 2025, at a CAGR of 10.6%. Growth in this market is attributed to a higher prevalence of cardiovascular diseases, rising awareness and early diagnosis, improved healthcare facilities in emerging markets, an aging population, and the introduction of high-sensitivity cardiac troponin assays.

How is the cardiac troponin market size expected to evolve during the forecast period?

The cardiac troponin market is set for significant growth in the coming years, reaching $6.32 billion by 2029 at a CAGR of 10.4%. Factors driving this growth include the rising prevalence of lifestyle-related cardiovascular conditions, expansion of cardiac care units, increased adoption of home healthcare, growth in personalized medicine, and demand for efficient and cost-effective diagnostics. Key trends include the integration of machine learning for data interpretation, expanding applications beyond acute coronary syndrome, advancements in multiplex testing, development of novel biomarkers, and progress in personalized medicine.

Get your cardiac troponin market report here!

https://www.thebusinessresearchcompany.com/report/cardiac-troponin-global-market-report

Which key drivers are propelling the cardiac troponin market’s growth?

The rising prevalence of heart-related conditions, including coronary artery disease, heart failure, arrhythmias, and congenital defects, is expected to drive the cardiac troponin market. Contributing factors include aging populations, sedentary lifestyles, poor diets, and increasing obesity and hypertension rates. Cardiac troponin serves as a highly sensitive biomarker for detecting heart muscle damage, aiding in the diagnosis of heart attacks and other cardiac events. For instance, the Report on Registration of Births and Deaths 2023 by the Registry of Births and Deaths, Immigration and Checkpoints Authority, Singapore, and Ministry of Health reported 5,302 deaths due to ischemic heart disease, slightly up from 5,290 in 2022. This growing prevalence is expected to fuel the cardiac troponin market.

What are the market segments in the cardiac troponin industry?

The cardiac troponinmarket covered in this report is segmented –

1) By Type: Troponin I, Troponin T

2) By Location Of Testing: Laboratory Setting, Point Of Care (Poc) Testing

3) By Application: Acute Coronary Syndrome, Myocardial Infraction, Congestive Heart Failure, Other Applications

4) By End User: Hospitals, Diagnostic Centers, Homecare Setting, Other End Users

Subsegments:

1) By Troponin I: Cardiac Troponin I (cTnI), Muscle Troponin I

2) By Troponin T: Cardiac Troponin T (cTnT), Skeletal Troponin T

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18986&type=smp

Which leading companies are shaping the growth of the cardiac troponin market?

Major companies operating in the cardiac troponin market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company, Laboratory Corporation of America Holdings (Labcorp), Zoetis Inc., bioMérieux SA, Beckman Coulter Inc., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Radiometer Medical ApS, Randox Laboratories Ltd., Fujirebio Diagnostics Inc., Meso Scale Diagnostics LLC., Singulex Inc., Diazyme Laboratories Inc., Response Biomedical Corporation, Eurolyser Diagnostica GmbH, LifeSign LLC

What key trends are currently impacting the cardiac troponin market’s development?

The cardiac troponin market’s leading companies are putting their focus on creating novel technologies, such as human serum-based quality control. This new focus aims to guarantee precise and dependable high-sensitivity troponin testing through providing multi-analyte controls. The application of human serum-based quality control in cardiac troponin examination guarantees test precision and dependability by utilizing human serum with pre-determined troponin levels to verify the effectiveness of the assay. For example, Bio-Rad Laboratories, Inc., a biotech research firm based in the U.S., released Cardiac Advance in May 2023. This is a four-level, multi-analyte quality control explicitly structured for high-sensitivity troponin testing. These controls, which are liquid and based on human serum, come in InteliQ 3-mL tubes, Liquichek 3-mL standard, and 2.5-mL compact vials. The controls come with 10 cardiac analytes, such as troponin, CK-MB, BNP/proBNP, and myoglobin, and are compatible with Siemens and Roche testing systems. The products can be found in the U.S., Europe, and some Asian markets.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18986

Which geographic areas are influencing the growth of the cardiac troponin market?

North America was the largest region in the cardiac troponin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac troponin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Cardiac Assist Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiac-assist-devices-and-equipment-global-market-report

Cardiac Biomarkers Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report

Cardiac Pacemakers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiac-pacemakers-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: